The state board of pharmacy shall annually conduct an on-site inspection of each opioid treatment program licensed under section 5119.37 of the Revised Code.
Amended by 132nd General Assembly File No. TBD, HB 111, §1, eff. 6/29/2019.
Added by 131st General Assembly File No. TBD, HB 4, §1, eff. 7/16/2015.